CAPTIS™: MDD to MDR CER Remediation of a Standalone Software
EU MDR Template Creation for a Global Multinational Life Sciences Manufacturer

Project Summary
A global multinational life sciences manufacturer required support for developing their templates, the Clinical Evaluation Plans (CEP), Clinical Evaluation Report (CER), Post-Market Clinical Follow-up (PMCF) Plan, and Post-Market Clinical Follow-up (PMCF) Report in compliance with the EU MDR. Additionally, to promote global convergence, the clinical evaluation was also compliant to relevant guidance documents from the Medical Device Coordination Group (MDCG) and the International Medical Device Regulators Forum (IMDRF) requirements for their product portfolio.
The client chose to leverage Celegence’s team of regulatory medical writers to create templates that ensured they were compliant with all EU MDR requirements. Utilizing our extensive expert network, we were able to complete the project in a cost-efficient and timely manner. The templates were expected to support multiple therapeutic areas (TAs) and assist authors of various levels of expertise with detailed instructions and guidance specific to stand-alone devices, drug-device combinations (DDC), and software as a medical device (SaMD).
The project included the development of CER, CEP, PMCF Plan, and PMCF Report templates to be used throughout the organization in the therapeutic areas of:
Celegence Solution & Approach:
Celegence partnered closely with the client to create templates with following key features:
Highlights:
Appropriate sections and subsections reflecting the requirements per the MDR, IMDRF, MDCG
Guideline based instructions for each section/subsection with brief examples as warranted
Detailed instructions for different scenarios as applicable
Standard text, editable examples, and instructional text in each section
Documents prepared in compliance with customer-specific style guide
Project Achievements
Templates with comprehensive and detailed instructions and guidance for the user where necessary
Cautions to the user for limiting information pertaining to drugs, in the case of combination products
Contents developed from Notified Body (NBs) perspective for DDC and SaMD
Developed customer’s new SOPs for compliant clinical evaluation and PMCF
100% quality & timeline delivery performance despite tight timelines, an achievement due to the collaboration with Celegence’s expansive expert network
If your organization needs support
in developing templates to complete the PMCF plan and clinical evaluation plans and reports, reach out to our expert medical writing team at info@celegence.com or find out more information on Celegence’s Medical Device capabilities
Learn MoreOther Related Articles
25 Mar, 2025
Contact Us Today
From document publishing automation to eCTD submissions and beyond, Celegence is your trusted partner for regulatory affairs excellence. Contact us to learn how we can help you achieve your compliance goals efficiently and cost-effectively.
"*" indicates required fields